Send us Feedback

Valeant Pharmaceuticals International (VRX)
Analysis
Data
Financials
No Sales Breakout Data.
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 521M 200M 140M 346M 262M
Short Term Investments 49.7M 19.2M 5.93M 107M 124M
Accounts Receivable 121M 145M 135M 149M 167M
Inventories 73.5M 73.0M 70.6M 85.2M 97.3M
Pre-paid Expenses 14.5M 17.6M 14.2M 14.2M 16.4M
Deferred Tax Assets 16.8M 16.2M 15.4M 19.0M 19.5M
Other Current Assets 15.3M 0 0 0 0
Total Current Assets 812M 470M 381M 721M 686M
Property, Plant & Equipment 103M 90.2M 84.2M 95.4M 122M
Goodwill & Intangibles 292M 582M 544M 561M 596M
Other Long-term Assets 32.0M 29.8M 26.7M 16.5M 14.7M
Total Long-Term Assets 463M 717M 688M 675M 738M
Total Assets 1.28B 1.19B 1.07B 1.40B 1.42B
Accounts Payable 55.7M 41.6M 29.1M 31.6M 40.4M
Accrued Expenses 0 0 0 0 0
Short Term Debt 586K 1.14M 822K 766K 48.4M
Other Current Liabilities 23.3M 18.0M 21.8M 20.0M 17.9M
Total Current Liabilities 212M 292M 248M 251M 436M
Long Term Debt 481M 448M 340M 649M 551M
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 215K 3.21M 3.35M 14.4M 18.1M
Other Long-term Liabilities 82.1M 241M 218M 163M 82.9M
Total Long-term Liabilities 563M 692M 561M 827M 652M
Minority Interest 0 0 18K 19K 19K
Total Liabilities 776M 984M 810M 1.08B 1.09B
Preferred Stock 0 0 0 0 0
Common Par 859K 818K 822K 824K 811K
Additional Paid-In Capital 1.13B 1.07B 1.14B 1.14B 1.11B
Retained Earnings -718M -883M -875M -842M -804M
Treasury Stock 0 0 0 0 0
Other Equity 82.2M 18.1M -11.1M 14.9M 26.4M
Total Shareholder's Equity 499M 203M 259M 317M 337M
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki